bpc 157 srbija BPC-157 Did the FDA Just Approve

Blood Pressure and Vascular Tone Hypertensive Rat Models In spontaneously hypertensive rats (SHR), a widely used genetic model of essential hypertension, BPC-157 given subcutaneously at 2 mcg/kg/day for 4 weeks reduced mean systolic blood pressure by approximately 17 mmHg compared to vehicle-treated SHR controls

This is the more concentrated option, producing smaller injection volumes for any given dose

Training and Certification The training for phlebotomists focuses on drawing blood, not on giving shots

Start: 200 mcg once daily Increase: Add ~200 mcg every 2 weeks as tolerated Target Range: 400600 mcg once daily Frequency: Once daily Cycle Length: Typically 812 weeks Timing: Any consistent daily time

AOD-9604 is the more-studied stabilized version Compound Human Growth Hormone (somatropin) Class Full-length recombinant hGH FDA Status FDA-approved for specific indications (GH deficiency, certain growth disorders, AIDS wasting) Evidence Strength Strong human evidence for approved indications